Clostridium Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridium Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) [Phase 3]
Phase 3 study of CB-183,315 in Clostridium difficile infection has completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) [Phase 3]
Phase 3 study of CB-183,315 in Clostridium difficile infection has completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection [Phase 2]
Phase 2 clinical trial update on fecal microbiota transplantation for severe Clostridium difficile infection (pseudomembranous colitis) has …
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Early FMT for C.Difficile [Phase 1, Phase 2]
Clinical trial update reporting early-phase results for fecal microbiota transplantation (FMT) in Clostridium difficile infection across Pha…
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections [Phase 3]
A Phase 3 clinical trial comparing rectal bacteriotherapy, fecal microbiota transplantation, or oral vancomycin for recurrent Clostridium di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001) [Phase 3]
Phase 3 trial update for MK-3415, MK-6072, and MK-3415A in participants on antibiotics for Clostridium difficile infection; study completed …
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002) [Phase 3]
Phase 3 study MK-6072 and MK-3415A in antibiotic-treated Clostridium difficile infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea [Phase 2]
Phase 2 trial update for microbiota restoration therapy in recurrent Clostridium difficile infection; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Study of CB-183,315 in Participants With Clostridium Difficile Infection [Phase 2]
Phase 2 clinical trial of CB-183,315 in participants with Clostridium difficile infection has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection [Phase 2]
Phase 2 trial update on VP20621 for prevention of recurrent Clostridium difficile infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating ACAM-CDIFF, a Clostridium difficile toxoid vaccine, in subjects …
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection [Phase 2]
Phase 2 trial evaluating CASAD (calcium aluminosilicate anti-diarrheal) for Clostridium difficile infection was terminated; results have bee…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers [Phase 1]
Phase 1 study assessing safety, tolerability, and immunogenicity of a Clostridium difficile toxoid vaccine in healthy adults, with results p…